- Lazurite Adds Intuitive Modern Medical Solutions as New Distributor of the ArthroFree System
- Tevogen Bio Announces $8 Million Equity Investment
- MB2 Dental Raises US$2.344bn Unitranche Debt Facility With KKR
- Thermo Fisher Scientific Launches New Ion Chromatography Instrument to Improve Reliability, Efficiency, and Functional Adaptability for Labs
- Sparrow BioAcoustics Announces the Launch of Stethophone™ – Bringing the Future of Personalized Heart Care Closer to Home
Medical Device News Magazine is a digital Publication Founded in 2008, and proudly located in the United States, Medical Device News Magazine has established itself as one of the foremost and most trusted sources of comprehensive updates and insights within the medical device and biotech industries. Our publication is committed to delivering timely and relevant information, making it a go-to resource for professionals and enthusiasts alike.
Medical Device News Magazine is easily accessible to readers 24/7/365, allowing you to stay informed at your convenience, and it presents content that is a fast and engaging read. We take pride in offering valuable insights in a format that can be consumed quickly, ensuring that our audience stays ahead of the curve.
Furthermore, if you are interested in expanding your reach and visibility within this dynamic field, we encourage you to inquire about advertising opportunities with us.
"Medical Device and Biotechnology Sector News: Essential Key Insights and Noteworthy Developments that are Shaping the Future"
inHEART Receives CE Certification Under New MDR for Novel AI-Based Digital Twin of the Heart
inHEART solution creates digital 3D models of the heart with unprecedented anatomical details, allowing physicians to better plan and personalize cardiac ablation procedures.
PathAI Announces IBD Explore, an AI-powered Histopathology Panel to Unlock Insights for Ulcerative Colitis from the Inflammatory Microenvironment
“IBD Explore provides visibility down to each individual cell in the inflammatory tissue environment and HIFs, and a level of granularity that we’ve never had,” said Andy Beck, M.D., Ph.D., chief executive officer and co-founder of PathAI. “This level of detail helps researchers identify patient subtypes and develop customized therapeutics with the hopes of greater efficacy and increased remission for UC patients.”
Bentley Launches the BeBack Crossing Catheter | Its 1st Product in the United States
The BeBack Crossing Catheter is designed for steering through Chronic Total Occlusions (CTO) that often is the most challenging part when treating heavily calcified lesions.
VTT Creates a Biodegradable ECG Patch
The new nanocellulose and carbon ECG patch aims to reduce the carbon footprint of plastics and electronics for one of the world’s largest waste-producing sectors: healthcare. VTT is currently looking for potential partners to bring manufacturing to industrial scale.
Innovative Solutions for Today's Challenges, Secured Funding for a Brighter Future
Delphinus Raises $30 Million in Series D Funding to Transform Dense Breast Screening
The round drew participation from both new and existing investors, including Arboretum Ventures, Beringea, North Coast Technology Investors, Venture Investors, Hopen Life Science Ventures, and Waycross Ventures.
Signum Surgical Secures Additional €2.9 Mil
Funds to support ongoing regulatory submissions and clinical programs leading to the commercialization of BioHealx reports Signum Surgical.
Industry Expert Byline
Reimagining CRM: What’s Next for Medtech Commercial Success | By Akshay Kapadia, CEO and Founder, Conexus Solutions, Inc.
Success depends on more than just choosing the right CRM platform; it requires aligning that platform with optimized business processes, a clear data strategy, and long-term commercial goals. When all of these elements work together, the CRM platform becomes a powerful tool to support growth, innovation, and sustained value.
Skin Cancer and Reconstructive Surgery Center of California Adopts AI-driven Nevisense for Early Skin Cancer Detection
The Nevisense System is a first-of-its-kind AI-driven technology that uniquely addresses the complexities of point-of-care detection of the deadliest form of skin cancer by providing clinicians with advanced analysis of irregular moles during routine skin checks.
Nona Biosciences Announces Collaboration Agreement with Lycia Therapeutics
“We are pleased to enter into this collaboration with Lycia Therapeutics, extending our service footprint to the area of extracellular protein degradation. We believe Lycia’s leveraging of our antibody discovery capabilities will help accelerate its efforts to advance novel protein degrader therapeutics,” said Jingsong Wang, M.D., Ph.D., Chairman of Nona Biosciences said.
Comprehensive Insights into Medical Device and Biotechnology Company Mergers and Acquisitions Trends and Strategies
Numotion Acquires Retail DME Market Leader SpinLife Creating Broader Portfolio of Independence and Mobility Solutions
The combined entity extends customer reach with more options to people with all levels of mobility-related needs.
Boston Scientific Exercises Option to Acquire Farapulse, Inc.
FARAPULSE Pulsed Field Ablation (PFA) System is a non-thermal ablation system for the treatment of atrial fibrillation (AF) and other cardiac arrhythmias.
FDA Medical Device Updates
Our Experts - Byline Articles
Medical Imaging Technologies and Their Impact on Modern Healthcare
Healing Headlines, Transforming Lives: Hospitals in the News
AI-powered CT System Launches Reports Philips
Philips CT 3500, is a new high-throughput CT system targeting the needs of routine radiology and high-volume screening programs. Powered by AI, the Philips CT 3500 includes a range of image-reconstruction and workflow-enhancing features that help to deliver the consistency, speed, and first-time-right image quality needed for confident diagnoses by clinicians and increased return on investment – even in the most demanding, high-volume care settings.
